Vivoryon Therapeutics

Vivoryon Therapeutics

Biopharmaceutical company focused on the development of innovative small molecule drugs.

Launch date
Employees
Market cap
AUD92.2m
Enterprise valuation
AUD44m (Public information from Sep 2024)
Halle (Saale) Saxony-Anhalt (HQ)
Authorizing premium user...